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carbipenems and fluorinated quinolones need clinical 
validation; however, in vitro susceptibility profile appears 
promising. 
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In eubacteria Escherichia coli and Bacillus subtilis, the 
glpTQ operon is involved in utilization of glycerol3- 
phosphate (G3P) as a carbon source, and the glpT and 
glpQ genes transcribe as a single unit. In Haemophilus 
influenzae, we have previously characterized the glpT 
and glpQ homologues encoding glycerol-3-phosphate 
permease and glycerophosphodiester phosphodiesterase, 
respectively. The protein encoded by glpQ is also called 
Protein D and is involved in pathogenesis. In this study, 
we analysed the glpTQ transcripts in one H. injluenzae 
type b (Hib) and one nontypeable (NTHi) strain, and 
characterized potential function of the 1.4 kb glpTQ 
intergenic region that exists in most Hib strains but not 
in NTHi strains. In Northern blot and RT-PCR analysis, 
the glpT and glpQ genes in the Hib strain transcribed 
separately, whereas a co-transcribed glpTQ was found in 
the NTHi strain. It suggests that the 1.4 kb glpTQ 
intergenic region in Hib strains partially blocks the 
glpTQ operon transcription. When an isogenic mutant 
strain where the 1.4 kb region was replaced with 
a kanamycin cassette in the chromosome of the wild- 
type strain was tested, the blockage of the glpTQ 
transcription disappeared. We therefore conclude that 
due to the existence of the 1.4 kb glpTQ intergenic 
region in Hib strains, the glpTQ operons between Hib 
and NTHi strains transcribed differently. Based on a 
much lower G+C content (26 %) of the 1.4 kb DNA 
coding region than an overall G+C content of 38 % for 
the H. influenzae genome, we speculate that the 1.4 kb 
region might have been acquired by lateral transfer from 
an organism with a lower G+C content. 
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Background: The aim of this open, uncontrolled study 
was to evaluate the reliability of IL for the treatment of 
microbiologically proven, uncomplicated CRBSI, in 
different categories of immunocompromised patients. 
Methods: IL is based on a daily intraluminal instillation 
of a pre-definite highly concentrated solution of 
antimicrobials into the colonized line, locked within the 
line for at least 12 hrs/day Then the solution is removed 
and the CVC eventually re-used. In our study locks 
were repeated along 14 days. Vancomycin or teicoplanin 
20 mg/ml were delivered for empirical locks, or in the 
presence of staphylococci, enterococci, micrococci and 
corynebacteria; amikacin 10 mg/ml or ciprofloxacin 2 
mg/ml for susceptible Gram-negative bacteria; tailored 
antimicrobials for Gram-negative with different patterns 
of chemosensitivity. Fungal CRBSI were excluded. 23 
patients, who had signs and symptoms of uncomplicated 
CRBSI, according to defined criteria, with AIDS (14) 
or haematological neoplasias (9) and carrying long-term 
central venous catheter (CVC) (tunnelled or totally im- 
plantable), were consecutively enrolled. Per protocol, 
they were all given locks plus systemic antimicrobial 
therapy during the first 48 hrs. After this time, once 
microbiological diagnosis had been proven, clinical 
reassessment was performed. If defervescence of fever 
occurred, the patient continued receiving IL alone or in 
combination with systemic therapy (same antimicrobials 
used for locks), according to the clinician’s decision. 
Results: Twelve underwent locks alone and 11 locks plus 
systemic therapy thereafter. 21/23 pts (91.3%) were 
cleared from infection and retained the line in place: 
12/12 in the IL arm and 9/11 in the IL plus systemic 
therapy arm, as of clinical and microbiological follow-up 
performed at 14 days after the completion of treatment. 
The only two failures occurred in the combined treatment 
arm and were due to polymicrobial infections (methi- 
cillin-resistant Staphylococcus aureus plus Gram-negative 
bacteria), treated with glycopeptide alone-based locks. 
Conclusions: This study, though limited, confirms that 
IL is an effective treatment option also for immuno- 
compromised patients. Furthermore IL alone seems to 
be at least as effective as IL plus systemic therapy in 
the treatment of uncomplicated CRBSI, for the high 
antimicrobial concentrations obtained directly within 
the site of infection; but it results also in negligible blood 
antimicrobial concentrations, thus limiting the risk of 
dose-dependent side-effects and making it appealing in 
pts with liver or renal impairment as well. 
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Background: Prospective surveillance of resistant 
bacterial pathogens is an indispensable tool of quality 
control in pediatric oncology departments. 
